O'Brien, S., Hammarén, H., Strouse, B., Antonysamy, M., Patnaik, D., Tran, H., Mazurek, A., McCabe, M. (2025). Momelotinib's unique polypharmacology supports indication expansion beyond myelofibrosis. Blood. https://doi.org/10.1182/blood-2025-7853